Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology

Jarushka Naidoo; Catherine Murphy; Michael B Atkins; Julie R Brahmer; Stephane Champiat; David Feltquate; Lee M Krug; Javid Moslehi; M Catherine Pietanza; Joanne Riemer; Caroline Robert; Elad Sharon; Maria E Suarez-Almazor; Karthik Suresh; Michelle Turner; Jeffrey Weber; Laura C Cappelli

doi:10.1136/jitc-2022-006398

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

PDF

Position article and guidelines

Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Naidoo J, Murphy C, Atkins MB, et al

Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology

Journal for ImmunoTherapy of Cancer 2023;11:e006398. doi: 10.1136/jitc-2022-006398

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password